Your browser doesn't support javascript.
loading
Single-cell transcriptomics identifies a WNT7A-FZD5 signaling axis that maintains fallopian tube stem cells in patient-derived organoids.
Alsaadi, Abdulkhaliq; Artibani, Mara; Hu, Zhiyuan; Wietek, Nina; Morotti, Matteo; Gonzalez, Laura Santana; Alazzam, Moiad; Jiang, Jason; Abdul, Beena; Soleymani Majd, Hooman; Blazer, Levi L; Adams, Jarret; Silvestri, Francesca; Sidhu, Sachdev S; Brugge, Joan S; Ahmed, Ahmed Ashour.
Afiliação
  • Alsaadi A; Ovarian Cancer Cell Laboratory, MRC Weatherall Institute of Molecular Medicine, University of Oxford, Oxford OX3 9DS, UK; Nuffield Department of Women's & Reproductive Health, University of Oxford, Oxford OX3 9DU, UK.
  • Artibani M; Ovarian Cancer Cell Laboratory, MRC Weatherall Institute of Molecular Medicine, University of Oxford, Oxford OX3 9DS, UK; Nuffield Department of Women's & Reproductive Health, University of Oxford, Oxford OX3 9DU, UK; Gene Regulatory Networks in Development and Disease Laboratory, MRC Weatherall
  • Hu Z; Ovarian Cancer Cell Laboratory, MRC Weatherall Institute of Molecular Medicine, University of Oxford, Oxford OX3 9DS, UK; Nuffield Department of Women's & Reproductive Health, University of Oxford, Oxford OX3 9DU, UK; Gene Regulatory Networks in Development and Disease Laboratory, MRC Weatherall
  • Wietek N; Ovarian Cancer Cell Laboratory, MRC Weatherall Institute of Molecular Medicine, University of Oxford, Oxford OX3 9DS, UK; Nuffield Department of Women's & Reproductive Health, University of Oxford, Oxford OX3 9DU, UK; Department of Gynecological Oncology, Churchill Hospital, Oxford University Ho
  • Morotti M; Ovarian Cancer Cell Laboratory, MRC Weatherall Institute of Molecular Medicine, University of Oxford, Oxford OX3 9DS, UK; Nuffield Department of Women's & Reproductive Health, University of Oxford, Oxford OX3 9DU, UK; Department of Gynecological Oncology, Churchill Hospital, Oxford University Ho
  • Gonzalez LS; Ovarian Cancer Cell Laboratory, MRC Weatherall Institute of Molecular Medicine, University of Oxford, Oxford OX3 9DS, UK; Nuffield Department of Women's & Reproductive Health, University of Oxford, Oxford OX3 9DU, UK.
  • Alazzam M; Department of Gynecological Oncology, Churchill Hospital, Oxford University Hospitals, Oxford OX3 7LE, UK.
  • Jiang J; Department of Gynecological Oncology, Churchill Hospital, Oxford University Hospitals, Oxford OX3 7LE, UK.
  • Abdul B; Department of Gynecological Oncology, Churchill Hospital, Oxford University Hospitals, Oxford OX3 7LE, UK.
  • Soleymani Majd H; Medical Sciences Division, University of Oxford, John Radcliffe Hospital, Oxford OX3 9DU, UK.
  • Blazer LL; School of Pharmacy, University of Waterloo, Waterloo, ON, Canada.
  • Adams J; School of Pharmacy, University of Waterloo, Waterloo, ON, Canada.
  • Silvestri F; Department of Cell Biology, Harvard Medical School, Boston, MA 02115, USA.
  • Sidhu SS; School of Pharmacy, University of Waterloo, Waterloo, ON, Canada.
  • Brugge JS; Department of Cell Biology, Harvard Medical School, Boston, MA 02115, USA; Ludwig Center at Harvard, Boston, MA, USA.
  • Ahmed AA; Ovarian Cancer Cell Laboratory, MRC Weatherall Institute of Molecular Medicine, University of Oxford, Oxford OX3 9DS, UK; Nuffield Department of Women's & Reproductive Health, University of Oxford, Oxford OX3 9DU, UK; Department of Gynecological Oncology, Churchill Hospital, Oxford University Ho
Cell Rep ; 42(11): 113354, 2023 11 28.
Article em En | MEDLINE | ID: mdl-37917586

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Beta Catenina / Tubas Uterinas Limite: Female / Humans Idioma: En Revista: Cell Rep Ano de publicação: 2023 Tipo de documento: Article País de afiliação: Reino Unido

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Beta Catenina / Tubas Uterinas Limite: Female / Humans Idioma: En Revista: Cell Rep Ano de publicação: 2023 Tipo de documento: Article País de afiliação: Reino Unido